Nintendo's latest sale is 'made possible' by the tariff refunds it's hoarding35m ago Instagram now lets you add tagged photos to your profile grid36m ago Meta Announces Muse AI Agent for Personal Tasks and Organization36m ago AI agents are flooding public services with new requests42m ago Apple’s first foldable is the iPhone Duo, and it costs $1,99943m ago An Anthropic researcher just quit, saying OpenAI and Anthropic are 'gambling with our lives'44m ago Anthropic Is Building a Huge Surveillance System to Spy on Anti-AI Activists and Predict Their Activities53m ago Antioch raises $32m to test robots in simulation before they touch hardware1h ago OpenAI’s Bubeck denies trying to cut Anthropic mathematician from credit1h ago 10 of the scariest AI villains in movie history1h ago Maven Robotics wants to steal your robot deployment deal1h ago Agent Security Is Not AI Governance: Why Conflating The Two Is A Risk Enterprises Can't Afford1h ago Positron Valued at $5 Billion in New Funding as Demand for AI Chips Surges1h ago 7 Steps to Become a Forward Deployed Engineer in 20262h ago

Nintendo's latest sale is 'made possible' by the tariff refunds it's hoarding35m ago Instagram now lets you add tagged photos to your profile grid36m ago Meta Announces Muse AI Agent for Personal Tasks and Organization36m ago AI agents are flooding public services with new requests42m ago Apple’s first foldable is the iPhone Duo, and it costs $1,99943m ago An Anthropic researcher just quit, saying OpenAI and Anthropic are 'gambling with our lives'44m ago Anthropic Is Building a Huge Surveillance System to Spy on Anti-AI Activists and Predict Their Activities53m ago Antioch raises $32m to test robots in simulation before they touch hardware1h ago OpenAI’s Bubeck denies trying to cut Anthropic mathematician from credit1h ago 10 of the scariest AI villains in movie history1h ago Maven Robotics wants to steal your robot deployment deal1h ago Agent Security Is Not AI Governance: Why Conflating The Two Is A Risk Enterprises Can't Afford1h ago Positron Valued at $5 Billion in New Funding as Demand for AI Chips Surges1h ago 7 Steps to Become a Forward Deployed Engineer in 20262h ago

Healthcare AI Research3 min reading time

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Covered by 2 sourcesPublished Jul 15, 2026

Miles Wang, an OpenAI researcher known for AI-driven scientific discovery, is leaving to start a drug discovery AI startup. The company is reportedly in talks to raise $200M at a $2B valuation, with Lightspeed as a potential lead investor. The startup aims to repurpose existing drugs using AI, accelerating drug development timelines.

Covered by 2 sources

#ai-drug-discovery #drug-repurposing #lightspeed #miles-wang #openai

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources17h ago

Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI5h ago

Healthcare3 min read

Google’s map of every possible DNA typo could speed up rare disease research

Covered by 3 sources2d ago